BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 1192561)

  • 1. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ; Boyd GW; Peart WS
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the renin-angiotensin system in hypertension produced by unilateral renal artery constriction in the rat.
    Oates HF
    Clin Exp Pharmacol Physiol; 1976; 3(1):95-8. PubMed ID: 971555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of saralasin infusion on bilateral renal function in two-kidney, one-clip Goldblatt hypertensive rats.
    Huang WC; Ploth DW; Navar LG
    Clin Sci (Lond); 1982 Jun; 62(6):573-9. PubMed ID: 7083749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
    Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
    Anderson GH; Streeten DH; Dalakos TG
    Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A; Hummerich W; Bönner G; Meurer KA; Moritz G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():208-9. PubMed ID: 613575
    [No Abstract]   [Full Text] [Related]  

  • 8. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of administration of Sar1-Ala8-angiotensin II during the development and maintenance of renal hypertension in the rat.
    Fernandes M; Fiorentini R; Onesti G; Bellini G; Gould AB; Hessan H; Kim KE; Swartz C
    Clin Sci Mol Med; 1978 Jun; 54(6):633-7. PubMed ID: 657733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition.
    Atkinson AB; Brown JJ; Fraser R; Lever AF; Morton JJ; Riegger AJ; Robertson JI
    Clin Exp Hypertens (1978); 1980; 2(3-4):499-524. PubMed ID: 6253241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic effects of sar1-ala8-angiotensin in patients with renovascular hypertension (author's transl)].
    Philipp T; Zschierdrich H; Distler A
    Klin Wochenschr; 1977 Sep; 55(18):917-9. PubMed ID: 916618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
    DeForrest JM; Knappenberger RC; Antonaccio MJ; Ferrone RA; Creekmore JS
    Am J Cardiol; 1982 Apr; 49(6):1515-7. PubMed ID: 6280481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
    Arlart IP; Rosenthal J; Wagner H; Adam WE; Nobbe F; Franz HE
    Contrib Nephrol; 1978; 11():170-4. PubMed ID: 699587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the renin-angiotensin system in dogs with perinephritis hypertension.
    Johnson JA; Stubbs D; Keitzer WF
    Proc Soc Exp Biol Med; 1976 Sep; 152(4):560-4. PubMed ID: 967886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of central and peripheral angiotensin blockade in hypertensive rats.
    Mann JF; Phillips MI; Dietz R; Haebara H; Ganten D
    Am J Physiol; 1978 May; 234(5):H629-37. PubMed ID: 645931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to angiotensin inhibition in rats with sustained renovascular hypertension correlates with response to removing renal artery stenosis.
    Pipinos II; Nypaver TJ; Moshin SK; Careterro OA; Beierwaltes WH
    J Vasc Surg; 1998 Jul; 28(1):167-77. PubMed ID: 9685143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of high sodium intake and angiotensin antagonist in rabbits with severe and moderate hypertension induced by constriction of one renal artery.
    Romero JC; Holmes DR; Strong CG
    Circ Res; 1977 May; 40(5 Suppl 1):I17-23. PubMed ID: 870227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and neurogenic factors in two-kidney renovascular hypertension.
    de la Riva IJ; Basso N; Kurnjek ML; Taquini AC
    Arch Int Physiol Biochim; 1980 May; 88(2):137-46. PubMed ID: 6159837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.